← Back to headlines
ORIC Pharmaceuticals Reports GAAP EPS of -$0.30, Beating Estimates
ORIC Pharmaceuticals released its latest financial results, reporting a GAAP EPS of -$0.30, which beat estimates by $0.06.
23 Feb, 22:06 — 23 Feb, 22:06
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
China leaves benchmark lending rates unchanged as Beijing signals tolerance for stronger yuan
12m ago
Keysight Reports Strong Q2 Revenue and EPS Growth Driven by AI and Defense Demand
22m ago
From Rs 47 crore PAT to Rs 252 crore in 3 quarters: Is CreditAccess Grameen’s worst behind it?
27m ago
UOB's fourth-quarter net profit dips 7%, beats forecasts
43m ago